Bristol Myers Squibb is hosting a panel discussion at AAPS PharmSci 360 2026 on October 26, 2026, featuring Dr. Parag Kolhe, Dr. Alfred Rumondor, and Dr. Ryan Soderquist from Pfizer, AbbVie, and Merck respectively.
Public source
Publisher name
Public post
Excited to share Part 1 of a pre-conference video interview with PharmTech, previewing our upcoming panel discussion at AAPS PharmSci 360 2026! 🎙️ Navigating CMC Strate…
Company
Bristol Myers Squibb
- Industry
- Pharmaceutical Manufacturing
- Location
- Lawrence Township, US
- Company size
- 10,001+ employees
About Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
See moreLatest activity
Latest activity from Bristol Myers Squibb
51 signals
Presence & Recognition
Bristol Myers Squibb France team will depart for the 11th edition of Country 2 Country 4 Cancer from 16 to 18 September.
Research & Knowledge
Bristol Myers Squibb announced positive topline results from a registrational Phase 2 trial evaluating an investigational CAR T cell therapy in certain patients with relapsed or refractory multiple myeloma.
People
Bristol Myers Squibb General Manager Spain & Portugal Sandra Orta accepted her new role in BMS in the United States.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
American Association of Pharmaceutical Scientists (AAPS) | @aapscomms
American Association of Pharmaceutical Scientists (AAPS) | @aapscomms announced that the AAPS Translational and Clinical Sciences Community will host an Open Scientific Discussion on the July FDA product-specific guidances on peptide products on Sept. 8, 2026, moderated by Vibha Jawa PhD FAAPS of EpiVax, Inc. and Daniela Verthelyi.
Presence & Recognition
Piramal Pharma Solutions
Piramal Pharma Solutions is exhibiting at Booth 104 at the Chem Outsourcing conference in Boston from September 15-17, 2026, to discuss integrated CDMO capabilities and program development.
Presence & Recognition
US Pharmacopeia
US Pharmacopeia is hosting and moderating the AAPS–USP Workshop at PharmSci 360 on October 26 to 28, 2026, to discuss pharmaceutical quality and standards.
Presence & Recognition
Hovione
Hovione expert Rui Loureiro is contributing to the scientific program with the session “From Molecules to Particles: An integrated approach to decarbonize pharmaceutical development” showcasing how Hovione is applying greener technologies, solvent recovery strategies, and sustainability metrics.
Presence & Recognition
Adare Pharma Solutions